Advanced search
Publication Cover
Cancer Management and Research Volume 12, 2020 - Issue
Submit an article Journal homepage
21
Views
10
CrossRef citations to date
0
Altmetric
Original Research

RETRACTED ARTICLE: Long Non-coding RNA BLACAT1 Induces Tamoxifen Resistance in Human Breast Cancer by Regulating miR-503/Bcl-2 Axis

Rongfeng Qu1 Department of Hematology and Oncology, The Second Hospital of Jilin University, Changchun 130041, Jilin, People’s Republic of China
,
Chunmei Hu1 Department of Hematology and Oncology, The Second Hospital of Jilin University, Changchun 130041, Jilin, People’s Republic of China
,
Yan Tang1 Department of Hematology and Oncology, The Second Hospital of Jilin University, Changchun 130041, Jilin, People’s Republic of China
,
Qiong Yu1 Department of Hematology and Oncology, The Second Hospital of Jilin University, Changchun 130041, Jilin, People’s Republic of China
&
Guang Shi1 Department of Hematology and Oncology, The Second Hospital of Jilin University, Changchun 130041, Jilin, People’s Republic of ChinaCorrespondence[email protected]
Pages 1771-1777 | Published online: 10 Mar 2020

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Xu Cao & Qiu-Ling Fan. (2020) LncRNA MIR503HG Promotes High-Glucose-Induced Proximal Tubular Cell Apoptosis by Targeting miR-503-5p/Bcl-2 Pathway. Diabetes, Metabolic Syndrome and Obesity 13, pages 4507-4517.
Read now

Articles from other publishers (9)

Jun Yao, Ruoyu Gao, Minghan Luo, Defeng Li, Liliangzi Guo, Zichao Yu, Feng Xiong, Cheng Wei, Benhua Wu, Zhenglei Xu, Dingguo Zhang, Jianyao Wang & Lisheng Wang. (2022) Exosomal LINC00460/miR-503-5p/ANLN positive feedback loop aggravates pancreatic cancer progression through regulating T cell–mediated cytotoxicity and PD-1 checkpoint. Cancer Cell International 22:1.
Crossref
Deepshikha Singh, Yehuda G. Assaraf & Rajesh N. Gacche. (2022) Long non-coding RNA mediated drug resistance in breast cancer. Drug Resistance Updates 63, pages 100851.
Crossref
Pingting Ye, Lei Feng, Shuo Shi & Chunyan Dong. (2022) The Mechanisms of lncRNA-Mediated Multidrug Resistance and the Clinical Application Prospects of lncRNAs in Breast Cancer. Cancers 14:9, pages 2101.
Crossref
Hamed Hosseinalizadeh, Mehrdad Mahmoodpour & Ammar Ebrahimi. (2021) Circulating non-coding RNAs as a diagnostic and management biomarker for breast cancer: current insights. Molecular Biology Reports 49:1, pages 705-715.
Crossref
America Campos, Shayna Sharma, Andreas Obermair & Carlos Salomon. (2021) Extracellular Vesicle-Associated miRNAs and Chemoresistance: A Systematic Review. Cancers 13:18, pages 4608.
Crossref
Jin-hai Tian, Shi-hai Liu, Chuan-yang Yu, Li-gang Wu & Li-bin Wang. (2021) The Role of Non-Coding RNAs in Breast Cancer Drug Resistance. Frontiers in Oncology 11.
Crossref
Jéssica Fernanda Barazetti, Tayana Shultz Jucoski, Tamyres Mingorance Carvalho, Rafaela Nasser Veiga, Ana Flávia Kohler, Jumanah Baig, Hend Al Bizri, Daniela Fiori Gradia, Sylvie Mader & Jaqueline Carvalho de Oliveira. (2021) From Micro to Long: Non-Coding RNAs in Tamoxifen Resistance of Breast Cancer Cells. Cancers 13:15, pages 3688.
Crossref
Min Zhu, Xiao Li, Shengtao Zhu, Peng Li, Li Min & Shutian Zhang. (2020) Long non-coding RNA BLACAT1, a novel promising biomarker and regulator of human cancers. Biomedicine & Pharmacotherapy 132, pages 110808.
Crossref
Wei Han, Fan Yu & Wei Guan. (2020) Oncogenic roles of lncRNA BLACAT1 and its related mechanisms in human cancers. Biomedicine & Pharmacotherapy 130, pages 110632.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.